CLL-IPI

The CLL-IPI, or Chronic Lymphocytic Leukemia International Prognostic Index, is a tool used by doctors to predict how a person with chronic lymphocytic leukemia (CLL) may respond to treatment and their overall outlook. It takes into account several factors, including the patient's age, whether the disease is advanced, and specific blood test results. By assessing these factors, the CLL-IPI helps healthcare providers make informed decisions about treatment options and can guide discussions about prognosis and management of the disease.